शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
SHALBYNSEShalby Limited· Healthcare ServicesHighNeutral
Announced Wed, 11 Feb, 2026 · 19:37 IST

Shalby Q3 FY26: Standalone PAT falls, board okays rights issue in PK Healthcare

SHALBY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-6.8%Reaction day
₹179.95
prior close
₹173.20
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.5%-6.3% vs market
Hospital peers, median of 23sector+0.5%-7.3% vs sector

On the reaction day the stock moved 6.3 pts less than Nifty Microcap 250 and 7.3 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-1.8
10m
-2.1
15m
-2.4
30m
-2.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-6.8-0.5-6.3+0.5-7.3
Next day
-12.5-2.0-10.5-0.9-11.6
2d
-14.1-2.7-11.4-0.5-13.6
3d
-11.2-1.7-9.4+1.1-12.3
4d
-11.6-1.4-10.1+0.8-12.4
5d
-13.0-2.8-10.2-0.7-12.4
1w
-14.8-2.8-12.0+0.3-15.1
15d
-16.9-8.4-8.5-3.5-13.5
1m
-15.5-9.1-6.4-4.3-11.3
2m
-14.4-4.0-10.4-3.7-10.7
3m
-11.8+2.6-14.5+4.0-15.8
UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 23Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Shalby Q3 FY26: Standalone revenue Rs 2,152.36M (vs Rs 2,206.40M YoY), PAT Rs 137.91M (vs Rs 208.58M YoY). Consolidated PAT was just Rs 12.78M vs loss of Rs 29.93M YoY. 9M FY26 standalone PAT fell to Rs 592.42M from Rs 688.35M. Board approved re-appointment of Independent Director Shyamal Joshi for 5 more years, rights issue of Rs 59.60 crore in subsidiary PK Healthcare, and strike-off of inactive step-down unit Ningen Lifecare.

Likely market impact

Mixed results: standalone PAT declined sharply YoY, but consolidated returned to profit. Subsidiary restructuring underway.